Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Launched by XIAOLIN CHEN, MD · Sep 24, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of advanced imaging techniques called multimodal computed tomography (CT) in patients who have experienced an acute hemorrhagic stroke, which is a type of stroke caused by bleeding in the brain. The goal is to better understand how these strokes occur, predict patient outcomes, and help guide treatment decisions. Hemorrhagic strokes can be serious and have a high risk of complications, so this research aims to improve care for patients facing this condition.

To participate in the trial, individuals should be between 18 and 85 years old and must have a current diagnosis of hemorrhagic stroke. However, those with a history of other types of strokes, serious health issues, or who have received certain treatments recently may not be eligible. Participants will undergo various imaging tests to help researchers gather important information about their condition. The trial is currently recruiting, and anyone interested should discuss it with their healthcare provider to see if it might be a good option for them or their loved ones.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. age ≥ 18, ≤ 85 years;
• • 2. presence with hemorrhagic stroke
• Exclusion Criteria:
• • 1. with a history of previous history of ischemic/hemorrhagic stroke;
• • 2. admission to the emergency department more than a week after symptom onset;
• • 3. serious medical history or existing comorbidities;
• • 4. physical disability due to previous diseases;
• • 5. prior treatment such as external ventricular drainage, digital subtraction angiography and lumbar puncture in other institution;
• • 6. poor original image quality;
• • 7. incomplete follow-up.